Remicade RA Therapy Meets Medicare Criteria For Infused Drug - Centocor
Centocor has been communicating with the Health Care Financing Administration regarding Medicare coverage for the newly approved rheumatoid arthritis indication for Remicade.
You may also be interested in...
Health Care Financing Administration procedures for bringing already-covered drugs under the outpatient prospective payment system would be tightly controlled in legislation introduced Sept. 23 by Sen. Hatch (R-Utah).
Supplemental BLA submitted July 15 for slowing structural damage and improving the signs and symptoms of early, active rheumatoid arthritis. FDA approved etanercept in November 1998 to treat moderately to severely active RA in patients with no successful drug alternatives and extended the indication to children in May
Immunex has agreed to perform large, prospectively defined studies to assess the risk of serious infection related to use of its rheumatoid arthritis therapy Enbrel (etanercept) following reports of sepsis and death with the product.